Sources | Names Used |
---|---|
CTRPv2 | BRD-K19103580 |
PharmacoGx | BRD-K19103580 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XCL1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | SLC13A3 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
mRNA | IMPG1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | ASCL4 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | PKD1L3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
mRNA | ABC13-47656900H15.1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | GPR101 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
mRNA | ACTG2 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | CTXN2 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | KIR3DL3 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |